KEITH JONES: Open Payments
NPI 1811178031 · GROVETON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 23 payments from 9 companies in 2025. Trend: 2023 $487 · 2024 $327 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $135 |
| Novo Nordisk Inc | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Inspire Medical Systems, Inc. | 1 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Viatris Specialty LLC | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
Products named: TRELEGY ELLIPTA, Ozempic, CAPLYTA, INSPIRE, AIRSUPRA, YUPELRI, Qelbree, FARXIGA.
Industry payments across TX — which companies pay providers there.
